KARSTEN BO JENSEN ApS, HOVSMED.dk

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.1% 2.1% 2.1% 2.1% 2.1%  
Bankruptcy risk  1.2% 1.1% 1.1% 1.0% 0.9%  
Credit score (0-100)  83 83 83 87 86  
Credit rating  A A A A A  
Credit limit (kDKK)  57.4 72.2 77.1 124.5 167.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  1,989 1,897 2,088 2,394 2,343  
EBITDA  377 390 346 544 575  
EBIT  261 310 258 449 446  
Pre-tax profit (PTP)  252.3 338.3 191.0 445.1 495.5  
Net earnings  187.5 274.0 153.6 341.4 418.0  
Pre-tax profit without non-rec. items  252 338 191 445 495  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  211 307 350 255 610  
Shareholders equity total  1,072 1,071 975 1,116 1,334  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,602 1,669 1,488 1,702 1,971  

Net Debt  -1,172 -1,041 -875 -1,148 -1,119  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,989 1,897 2,088 2,394 2,343  
Gross profit growth  -14.9% -4.6% 10.1% 14.6% -2.1%  
Employees  0 4 4 4 4  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,602 1,669 1,488 1,702 1,971  
Balance sheet change%  -9.6% 4.2% -10.8% 14.4% 15.8%  
Added value  377.4 389.9 346.4 538.2 575.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -234 15 -46 -190 225  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  13.1% 16.3% 12.3% 18.8% 19.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  16.5% 21.5% 17.8% 28.5% 27.5%  
ROI %  25.0% 32.9% 27.5% 43.5% 41.2%  
ROE %  16.8% 25.6% 15.0% 32.7% 34.1%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  66.9% 64.2% 65.5% 65.6% 67.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -310.5% -267.0% -252.7% -210.9% -194.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.8 2.4 2.2 2.8 2.3  
Current Ratio  2.8 2.5 2.3 2.9 2.4  
Cash and cash equivalent  1,171.8 1,040.8 875.3 1,147.6 1,119.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  484.5 357.4 272.0 547.9 329.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 97 87 135 144  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 97 87 136 144  
EBIT / employee  0 77 64 112 112  
Net earnings / employee  0 68 38 85 104